Table 2 Frequency of patients according to the demographic and clinical variables

From: Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population

Variable

Category

n (%)

Sex

Males

62 (55.8)

 

Females

49 (44.2)

Age

<40 years

38 (34)

 

40–59 years

61 (55)

 

60 years

12 (11)

Hospital stay

12 days

57 (62)

 

>12 days

35 (38)

Oral risperidone dosages

<6 mg per day

44 (47)

 

6–9 mg per day

28 (30)

 

>9 mg per day

21 (23)

Intramuscular

0 mg

81 (73)

risperidone dosages

<50 mg per 2 weeks 50 mg per 2 weeks

9 (8.1) 19 (17.1)

Concomitant treatments

Anticholinergics

21 (21)

 

Antidepressants

10 (9)

 

Antiepileptics

12 (10.8)

 

Atypical antipsychotics

7 (6.3)

 

Benzodiazepines

54 (48.6)

 

Classical antipsychotics

12 (10.8)

 

Lithium

2 (1.8)

  1. There were missing data for hospital stay (19) and risperidone dosages (11 for oral and 2 for intramuscular).